BSX · 8-K · 20260518PR000042
Capital Return Program
BOSTON SCIENTIFIC CORP · 2026-05-18 · Importance 54 · Surprise 42 · In source text
Boston Scientific entered into a $2 billion accelerated share repurchase agreement with JPMorgan Chase as part of its previously authorized $5 billion common-stock repurchase program. The company will initially receive shares valued at 80% of the repurchase price, representing approximately 30.4 million shares based on the May 15, 2026 closing price of $52.68. Final shares repurchased will be determined using the volume-weighted average share price during the ASR term, less a discount, with final settlement expected by June 30, 2026. Following the ASR, $3 billion will remain available under the authorization, and the transaction is expected to increase full-year 2026 adjusted EPS by $0.02 relative to prior guidance.
Key facts
- On May 18, 2026 Boston Scientific Corporation announced it has entered into an accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank, National Association for $2 billion (the repurchase price) of its common stock. source
- Under the terms of the ASR, Boston Scientific will pay the repurchase price and receive common stock with an aggregate value of 80% of the repurchase price based on the closing share price of the company’s common stock as of May 15, 2026. source
- The 80% aggregate value under the ASR represents approximately 30.4 million shares based on the May 15, 2026 closing price of $52.68. source
- Following completion of the ASR, Boston Scientific will have $3 billion remaining available under the share repurchase authorization. source
- The final settlement of the ASR is expected to be completed by June 30, 2026. source
- The ASR is part of Boston Scientific's previously announced $5 billion share repurchase authorization. source
- The total number of shares that Boston Scientific will ultimately repurchase under the ASR will be determined based on the volume weighted average price of the company’s common stock during the term of the ASR, less a discount and subject to adjustments pursuant to the terms and conditions of the ASR agreement. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | — | On May 18, 2026 Boston Scientific Corporation announced it has entered into an accelerated share repurchase (ASR) agreement with JPMorgan… |